Vice President, Global Marketing @ Teva Pharmaceuticals
Vice President, US & Global Marketing @ Otsuka Pharmaceutical Companies (U.S.)
Global Commercial Lead, Alzheimer’s disease @ Pfizer
Enterprising commercial development leader with over 18 years experience in biotech and pharmaceutical industries. Demonstrated skills in leadership, innovation, project execution, and management of joint ventures. Reputation for successful management of complex teams and development of talent. Extensive and diverse experience in marketing, operations, sales and sales management of biologics, vaccines, and small molecules across products in
Enterprising commercial development leader with over 18 years experience in biotech and pharmaceutical industries. Demonstrated skills in leadership, innovation, project execution, and management of joint ventures. Reputation for successful management of complex teams and development of talent. Extensive and diverse experience in marketing, operations, sales and sales management of biologics, vaccines, and small molecules across products in all life cycle stages.
Specialties: Marketing, Brand Development, Commercial Market Development, Sales, Sales Management, Commercial Operations, BioPharmaceutical Commercial Strategy, Alliance Management, Alzheimer's disease, Major Depressive Disorder, Schizophrenia, Bipolar Disorder, and Anxiety Disorders.
Sr. Director, Neuroscience Marketing @ Responsible for the U.S. portfolio of oral neuroscience brands.
Commercial lead for the top selling US Pharmaceutical Brand.
Lead commercialization and upcoming US launch of a new CNS brand. From March 2013 to Present (2 years 10 months) Global Brand Leader, Alzheimer's Immunotherapy Program @ Responsible for commercial development of assets for Alzheimer’s disease (AD) and co-chair the Joint Leadership Team, responsible for clinical/commercial development strategy and execution plan in preparation of a novel immunotherapy for AD. Managed the Joint Venture with Janssen AI, a Johnson and Johnson company, to create a governance model and foster a collaborative partnership. From October 2009 to March 2013 (3 years 6 months) Sr. Director, Neuroscience New Business @ Led early commercial development of the Alzheimer’s disease (AD) portfolio and other neuroscience assets by assessing market opportunities and completing product valuations. Spearheaded the initial brand and market development activities to prepare for the launch of immunotherapies for the treatment of AD. From September 2007 to October 2009 (2 years 2 months) Operations Director, US and Pharmaceuticals @ Led day-to-day business operations for the US and Pharmaceuticals business units (BU) reporting to BU President. Oversaw development of BU objectives and measured performance metrics. Managed the diversified products portfolio and associated business partnerships.
•Developed US and BU objectives and performance metrics
•Managed P&L of a portfolio of 3 diversified products and maintained relationships with business partners
•Led the Portfolio Management Process for valuing BU pipeline assets
•Developed or approved all internal and external presentations and communications for BU/US President
•Liaised between CEO Office and BU/US President in preparation for earnings calls and investor meetings
•Administered MBA recruitment program and supervised MBA rotational hires and interns
•Collaborated with finance to manage the short and long-term budgeting process for the BU
•Oversaw all BU Meetings and events From May 2006 to August 2007 (1 year 4 months) Greater Philadelphia AreaNeuroscience Marketing @ Led the U.S. Health Care Professional and Payer strategy and tactical development for Effexor XR becoming the highest selling branded antidepressant
•Developed new strategic focus and campaigns for depression and anxiety which led to a resurgence of sales
•Led the strategic development and execution of the launch into Panic Disorder
•Developed managed care plan allowing preferred access to Effexor XR in over 97% of commercial plans From November 2003 to May 2006 (2 years 7 months) Area Development Manager @ Managed development of new business opportunities, sales representatives and managers, and operations for Women’s Health Care Business Unit From January 2002 to November 2003 (1 year 11 months) Greater Chicago AreaDistrict Sales Manager @ Managed 12 territory representatives and 1 Rheumatology Specialty Manager in Kentucky, Indiana, Ohio and Illinois.
Launched 2 new products including Enbrel (Rheumatoid Arthritis) and Protonix (GI). From March 1999 to December 2001 (2 years 10 months) Senior Sales Analyst @ Analyzed and provided recommendations on sales data and trends relevant to the Wyeth-Ayerst National Sales Force. From June 1998 to March 1999 (10 months) Greater Philadelphia AreaSales Representative @ Sold products to hospitals and healthcare professionals including Cardiologist, Infectious Disease, Pulmonary Specialist, Endocrinologist, Orthopedics, Pain Management, General Surgeons, Rheumatologist, Pediatrics, Internists, and Primary Care Physicians based on specific objectives and plans.
Launched 2 new products in pain and endocrinology. From August 1996 to June 1998 (1 year 11 months) Agency Sales Representative @ Sold document systems including copiers, faxes, and printers.
Established new commercial accounts through cold-calling and managed existing accounts. From January 1994 to July 1996 (2 years 7 months)
B.S., Business Administration & Marketing @ Columbia College From 1994 to 1996 University of Missouri-Columbia From 1991 to 1994 Aaron Deves is skilled in: Pharmaceutical Industry, Rheumatology, Strategy, Endocrinology, Managed Care, Biotechnology, Infectious Diseases, Sales Operations, Vaccines, Leadership, Strategic Planning, Business Strategy, Management, New Business Development, Marketing
Looking for a different
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension